Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest Chronic lower respiratory diseases Stories

2013-10-28 08:29:11

Phase 2 and Phase 3 data presented at the 2013 American College of Chest Physicians (ACCP) annual meeting RIDGEFIELD, Conn., Oct. 28, 2013 /PRNewswire/ -- Boehringer Ingelheim today presented the latest data for tiotropium in asthma at the 2013 American College of Chest Physicians (ACCP) annual meeting (CHEST 2013) in Chicago. The CHEST session "Tiotropium and Asthma" features a total of four oral presentations from Phase 2 and 3 studies of tiotropium delivered via the...

2013-10-28 08:28:21

MOUNTAIN VIEW, Calif., Oct. 28, 2013 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that enrollment in the REVOLENS Study, a cost-effectiveness study of the PneumRx RePneu Lung Volume Reduction Coil (RePneu LVRC) in France, has been completed. The REVOLENS study was submitted last year to the French Ministry of Health by Professors Gaetan Deslee of the University Hospital of Reims and Charles-Hugo Marquette of the...

2013-09-26 08:26:53

MOUNTAIN VIEW, Calif., Sept. 26, 2013 /PRNewswire/ -- PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil (LVRC) System for patients with severe emphysema. (Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO) The RePneu LVRC is a minimally invasive device intended to improve lung function, exercise capacity and quality of life in emphysema patients by bronchoscopically...

2013-09-11 23:03:17

The number of patients using oxygen therapy in Europe is expected to increase significantly as the population ages and past smokers develop emphysema and related conditions. Vancouver, BC (PRWEB) September 11, 2013 According to a report from iData Research entitled, Markets for Anesthesia, Respiratory and Sleep-Management Devices published September 1st 2013, the European oxygen therapy device market mimics former growth trends in the U.S. as it climbs to nearly €59 million and is...

2013-09-10 16:24:41

New Phase 3 data presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 RIDGEFIELD, Conn., Sept. 10, 2013 /PRNewswire/ -- Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma(®) program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma(®) Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the...

2013-09-10 12:29:33

Name change coincides with announcement of new apps and sensors for COPD, new data on outcomes MADISON, Wis., Sept. 10, 2013 /PRNewswire/ -- Asthmapolis, the FDA-cleared mobile health solution for chronic respiratory disease, today announced the company is changing its name to Propeller Health. The Propeller platform is designed to help patients and their physicians better understand and control respiratory disease to reduce preventable emergency room visits, hospitalizations and...

2013-09-08 20:20:21

Results presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 RIDGEFIELD, Conn., Sept. 8, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the results of TIOSPIR(TM) (Tiotropium Safety and Performance in Respimat) (NCT01126437), one of the largest international chronic obstructive pulmonary disease (COPD) trials conducted to date, at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, Spain. The...

2013-08-27 08:27:23

SAN DIEGO, Aug. 27, 2013 /PRNewswire/ -- Carolus Therapeutics, Inc. and The Alpha-1 Project, Inc. (TAP), a wholly-owned subsidiary of the Alpha-1 Foundation, today announced that they are collaborating to characterize human biological samples for the presence of the novel target, RANTES:PF4 heterodimer (the heteromer), a soluble protein complex that is secreted by activated platelets and implicated in many inflammation-related diseases, including genetic emphysema and COPD...

2013-08-16 04:20:20

OXFORD, England, August 16, 2013 /PRNewswire/ -- PSX1002 is a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has completed all patient dosing sessions and follow-up procedures in its Phase 2 clinical study with PSX1002. PSX1002 is a novel,...

2013-07-29 23:28:42

Mike quit smoking 2 packs a day after 2 hypnosis sessions with Goldlite Hypnosis Institute. Newport Beach, CA (PRWEB) July 28, 2013 Mike has been smoking for the last 30 years. He knew that cigarettes are very bad and destructive for his health, but he did not care. He always thought that he was young and healthy and never believed that smoking could cause him harm. Sixth months ago, Mike started having problems with breathing. He went to see a doctor who did multiple tests for him and...


Latest Chronic lower respiratory diseases Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »